{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T06:18:35Z","timestamp":1772173115202,"version":"3.50.1"},"update-to":[{"DOI":"10.1371\/journal.pcbi.1010332","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T00:00:00Z","timestamp":1666828800000}}],"reference-count":69,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T00:00:00Z","timestamp":1665964800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"abstract":"<jats:p>\n                    It is complicated to identify cancer-causing mutations. The recurrence of a mutation in patients remains one of the most reliable features of mutation driver status. However, some mutations are more likely to happen than others for various reasons. Different sequencing analysis has revealed that cancer driver genes operate across complex pathways and networks, with mutations often arising in a mutually exclusive pattern. Genes with low-frequency mutations are understudied as cancer-related genes, especially in the context of networks. Here we propose a machine learning method to study the functionality of mutually exclusive genes in the networks derived from mutation associations, gene-gene interactions, and graph clustering. These networks have indicated critical biological components in the essential pathways, especially those mutated at low frequency. Studying the network and not just the impact of a single gene significantly increases the statistical power of clinical analysis. The proposed method identified important driver genes with different frequencies. We studied the function and the associated pathways in which the candidate driver genes participate. By introducing lower-frequency genes, we recognized less studied cancer-related pathways. We also proposed a novel clustering method to specify driver modules. We evaluated each driver module with different criteria, including the terms of biological processes and the number of simultaneous mutations in each cancer. Materials and implementations are available at:\n                    <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/github.com\/MahnazHabibi\/MutationAnalysis\" xlink:type=\"simple\">https:\/\/github.com\/MahnazHabibi\/MutationAnalysis<\/jats:ext-link>\n                    .\n                  <\/jats:p>","DOI":"10.1371\/journal.pcbi.1010332","type":"journal-article","created":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T13:39:18Z","timestamp":1666013958000},"page":"e1010332","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["A new machine learning method for cancer mutation analysis"],"prefix":"10.1371","volume":"18","author":[{"given":"Mahnaz","family":"Habibi","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2741-0355","authenticated-orcid":true,"given":"Golnaz","family":"Taheri","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2022,10,17]]},"reference":[{"issue":"3","key":"pcbi.1010332.ref001","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1073\/pnas.0912629107","article-title":"Rate, molecular spectrum, and consequences of human mutation","volume":"107","author":"M Lynch","year":"2010","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"7132","key":"pcbi.1010332.ref002","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nature05610","article-title":"Patterns of somatic mutation in human cancer genomes","volume":"446","author":"C Greenman","year":"2007","journal-title":"Nature"},{"issue":"2","key":"pcbi.1010332.ref003","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","article-title":"Tumour heterogeneity and resistance to cancer therapies","volume":"15","author":"I Dagogo-Jack","year":"2018","journal-title":"Nature reviews Clinical oncology"},{"issue":"8","key":"pcbi.1010332.ref004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13059-014-0453-8","article-title":"Deciphering intratumor heterogeneity and temporal acquisition of driver events to refine precision medicine","volume":"15","author":"C Hiley","year":"2014","journal-title":"Genome biology"},{"issue":"2","key":"pcbi.1010332.ref005","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1039\/C7IB00135E","article-title":"Exploring candidate biomarkers for lung and prostate cancers using gene expression and flux variability analysis","volume":"10","author":"Y Asgari","year":"2018","journal-title":"Integrative Biology"},{"issue":"7216","key":"pcbi.1010332.ref006","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/nature07385","article-title":"Comprehensive genomic characterization defines human glioblastoma genes and core pathways","volume":"455","author":"Cancer Genome Atlas (TCGA) Research Network","year":"2008","journal-title":"Nature"},{"issue":"7484","key":"pcbi.1010332.ref007","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature12912","article-title":"Discovery and saturation analysis of cancer genes across 21 tumour types","volume":"505","author":"MS Lawrence","year":"2014","journal-title":"Nature"},{"issue":"6","key":"pcbi.1010332.ref008","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.cell.2012.08.029","article-title":"Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing","volume":"150","author":"M Imielinski","year":"2012","journal-title":"Cell"},{"issue":"6127","key":"pcbi.1010332.ref009","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1126\/science.1235122","article-title":"Cancer genome landscapes","volume":"339","author":"B Vogelstein","year":"2013","journal-title":"Science"},{"issue":"3","key":"pcbi.1010332.ref010","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/21541248.2016.1212689","article-title":"What makes oncogenes mutually exclusive?","volume":"8","author":"J Cisowski","year":"2017","journal-title":"Small GTPases"},{"issue":"10","key":"pcbi.1010332.ref011","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.molmed.2004.08.008","article-title":"Mutations and addiction to EGFR: the Achilles \u2018heal\u2019of lung cancers?","volume":"10","author":"AF Gazdar","year":"2004","journal-title":"Trends in molecular medicine"},{"issue":"2","key":"pcbi.1010332.ref012","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1101\/gr.125567.111","article-title":"Mutual exclusivity analysis identifies oncogenic network modules","volume":"22","author":"G Ciriello","year":"2012","journal-title":"Genome research"},{"issue":"1","key":"pcbi.1010332.ref013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13059-015-0612-6","article-title":"Systematic identification of cancer driving signaling pathways based on mutual exclusivity of genomic alterations","volume":"16","author":"\u00d6 Babur","year":"2015","journal-title":"Genome biology"},{"key":"pcbi.1010332.ref014","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3389\/fgene.2019.00155","article-title":"A comprehensive survey of tools and software for active subnetwork identification","volume":"10","author":"H Nguyen","year":"2019","journal-title":"Frontiers in genetics"},{"issue":"3","key":"pcbi.1010332.ref015","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1109\/TCBB.2016.2640963","article-title":"The discovery of mutated driver pathways in cancer: models and algorithms","volume":"15","author":"J Zhang","year":"2016","journal-title":"IEEE\/ACM transactions on computational biology and bioinformatics"},{"issue":"1","key":"pcbi.1010332.ref016","first-page":"e1364","article-title":"Computational approaches for the identification of cancer genes and pathways","volume":"9","author":"CM Dimitrakopoulos","year":"2017","journal-title":"Wiley Interdisciplinary Reviews: Systems Biology and Medicine"},{"issue":"16","key":"pcbi.1010332.ref017","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1093\/nar\/gkz566","article-title":"WITER: a powerful method for estimation of cancer-driver genes using a weighted iterative regression modelling background mutation counts","volume":"47","author":"L Jiang","year":"2019","journal-title":"Nucleic acids research"},{"issue":"1","key":"pcbi.1010332.ref018","first-page":"1","article-title":"Detailed modeling of positive selection improves detection of cancer driver genes","volume":"10","author":"S Zhao","year":"2019","journal-title":"Nature communications"},{"issue":"2","key":"pcbi.1010332.ref019","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng.3168","article-title":"Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes","volume":"47","author":"MD Leiserson","year":"2015","journal-title":"Nature genetics"},{"issue":"1","key":"pcbi.1010332.ref020","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nmeth.4514","article-title":"NetSig: network-based discovery from cancer genomes","volume":"15","author":"H Horn","year":"2018","journal-title":"Nature methods"},{"issue":"1","key":"pcbi.1010332.ref021","first-page":"1","article-title":"MUFFINN: cancer gene discovery via network analysis of somatic mutation data","volume":"17","author":"A Cho","year":"2016","journal-title":"Genome biology"},{"issue":"3","key":"pcbi.1010332.ref022","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.cels.2017.09.003","article-title":"Network-based coverage of mutational profiles reveals cancer genes","volume":"5","author":"BH Hristov","year":"2017","journal-title":"Cell systems"},{"issue":"9","key":"pcbi.1010332.ref023","doi-asserted-by":"crossref","first-page":"1800640","DOI":"10.1002\/advs.201800640","article-title":"MaxMIF: a new method for identifying cancer driver genes through effective data integration","volume":"5","author":"Y Hou","year":"2018","journal-title":"Advanced Science"},{"issue":"3","key":"pcbi.1010332.ref024","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nrc1299","article-title":"A census of human cancer genes","volume":"4","author":"PA Futreal","year":"2004","journal-title":"Nature reviews cancer"},{"issue":"1","key":"pcbi.1010332.ref025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep02651","article-title":"The mutational landscape of phosphorylation signaling in cancer","volume":"3","author":"J Reimand","year":"2013","journal-title":"Scientific reports"},{"issue":"2","key":"pcbi.1010332.ref026","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.cell.2018.02.060","article-title":"Comprehensive characterization of cancer driver genes and mutations","volume":"173","author":"MH Bailey","year":"2018","journal-title":"Cell"},{"issue":"2","key":"pcbi.1010332.ref027","doi-asserted-by":"crossref","first-page":"bbab548","DOI":"10.1093\/bib\/bbab548","article-title":"Comprehensive evaluation of computational methods for predicting cancer driver genes","volume":"23","author":"X Shi","year":"2022","journal-title":"Briefings in Bioinformatics"},{"issue":"7","key":"pcbi.1010332.ref028","doi-asserted-by":"crossref","first-page":"e0255270","DOI":"10.1371\/journal.pone.0255270","article-title":"Topological network based drug repurposing for coronavirus 2019","volume":"16","author":"M Habibi","year":"2021","journal-title":"Plos one"},{"issue":"D1","key":"pcbi.1010332.ref029","doi-asserted-by":"crossref","first-page":"D369","DOI":"10.1093\/nar\/gkw1102","article-title":"The BioGRID interaction database: 2017 update","volume":"45","author":"A Chatr-Aryamontri","year":"2017","journal-title":"Nucleic acids research"},{"key":"pcbi.1010332.ref030","article-title":"APID database: redefining protein\u2013protein interaction experimental evidences and binary interactomes","author":"D Alonso-L\u00f3pez","year":"2010","journal-title":"Database"},{"issue":"1","key":"pcbi.1010332.ref031","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2142\/biophysics.1.21","article-title":"Hint: a database of annotated protein-protein interactions and their homologs","volume":"1","author":"A Patil","year":"2005","journal-title":"Biophy"},{"issue":"D1","key":"pcbi.1010332.ref032","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/nar\/gkw985","article-title":"HIPPIE v2.0: enhancing meaningfulness and reliability of protein-protein interaction networks","volume":"45","author":"G Alanis-Lobato","year":"2016","journal-title":"Nucleic acids research"},{"issue":"7803","key":"pcbi.1010332.ref033","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41586-020-2188-x","article-title":"A reference map of the human binary protein interactome","volume":"580","author":"K Luck","year":"2020","journal-title":"Nature"},{"issue":"D1","key":"pcbi.1010332.ref034","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/nar\/gky1049","article-title":"Uniprot: a worldwide hub of protein knowledge","volume":"47","author":"U Consortium","year":"2019","journal-title":"Nucleic acids Res"},{"issue":"1","key":"pcbi.1010332.ref035","first-page":"330","article-title":"The gene ontology resource: 20 years and still going strong","volume":"47","author":"G Ontology","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"pcbi.1010332.ref036","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2307\/3033543","article-title":"A set of measures of centrality based on betweenness","volume":"1","author":"LC Freeman","year":"1977","journal-title":"Sociometry"},{"key":"pcbi.1010332.ref037","doi-asserted-by":"crossref","unstructured":"Xing W, Ghorbani A. Weighted pagerank algorithm. Conference on Communication Networks and Services Research, 1:305-314, 2004.","DOI":"10.1109\/DNSR.2004.1344743"},{"key":"pcbi.1010332.ref038","doi-asserted-by":"crossref","unstructured":"Ayati M, Taheri G, Arab S, Wong L, Eslahchi C. Overcoming drug resistance by co-targeting. IEEE International Conference on Bioinformatics and Biomedicine (BIBM), 18:198-202, 2010.","DOI":"10.1109\/BIBM.2010.5706562"},{"key":"pcbi.1010332.ref039","article-title":"Follistatin-Like 3 Enhances Invasion and Metastasis via \u03b2-Catenin-Mediated EMT and Aerobic Glycolysis in Colorectal Cancer","volume":"2077","author":"Y Li","year":"2021","journal-title":"Frontiers in cell and developmental biology"},{"key":"pcbi.1010332.ref040","first-page":"1","article-title":"Differential expression and clinical significance of COX6C in human diseases","volume-title":"American Journal of Translational Research","author":"BX Tian","year":"2021"},{"issue":"11","key":"pcbi.1010332.ref041","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-019-2068-1","article-title":"A functional genetic screen identifies the Mediator complex as essential for SSX2-induced senescence","volume":"10","author":"NH Br\u00fcckmann","year":"2019","journal-title":"Cell death & disease"},{"issue":"51","key":"pcbi.1010332.ref042","doi-asserted-by":"crossref","first-page":"29601","DOI":"10.18632\/oncotarget.25642","article-title":"LMO1 functions as an oncogene by regulating TTK expression and correlates with neuroendocrine differentiation of lung cancer","volume":"9","author":"L Du","year":"2018","journal-title":"Oncotarget"},{"key":"pcbi.1010332.ref043","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.3389\/fimmu.2018.01821","article-title":"Targeting B cell maturation antigen (BCMA) in multiple myeloma: potential uses of BCMA-based immunotherapy","volume":"9","author":"SF Cho","year":"2018","journal-title":"Frontiers in immunology"},{"key":"pcbi.1010332.ref044","doi-asserted-by":"crossref","first-page":"5380","DOI":"10.3389\/fonc.2020.538064","article-title":"Biological function of PD-L2 and correlation with overall survival in type II endometrial cancer","volume":"10","author":"O Marinelli","year":"2020","journal-title":"Frontiers in Oncology"},{"issue":"8","key":"pcbi.1010332.ref045","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1158\/2159-8290.CD-17-0151","article-title":"AACR Project GENIE: powering precision medicine through an international consortium","volume":"7","author":"Consortium AACR Project Genie","year":"2017","journal-title":"Cancer discovery"},{"issue":"10","key":"pcbi.1010332.ref046","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1158\/0008-5472.CAN-12-4403","article-title":"\u03b2-Catenin\/POU5F1\/SOX2 transcription factor complex mediates IGF-I receptor signaling and predicts poor prognosis in lung adenocarcinoma","volume":"73","author":"C Xu","year":"2013","journal-title":"Cancer research"},{"issue":"4","key":"pcbi.1010332.ref047","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1111\/jcmm.14082","article-title":"HMGA1 in cancer: Cancer classification by location","volume":"23","author":"Y Wang","year":"2019","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"3","key":"pcbi.1010332.ref048","first-page":"727","article-title":"PD-1\/PD-L1 pathway: current researches in cancer","volume":"10","author":"Y Han","year":"2020","journal-title":"American journal of cancer research"},{"issue":"2","key":"pcbi.1010332.ref049","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10238-021-00742-8","article-title":"RMI2 is a prognostic biomarker and promotes tumor growth in hepatocellular carcinoma","volume":"22","author":"Y Li","year":"2022","journal-title":"Clinical and experimental medicine"},{"issue":"1","key":"pcbi.1010332.ref050","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3892\/ol.2020.11607","article-title":"SPAG6 silencing induces autophagic cell death in SKM\u20111 cells via the AMPK\/mTOR\/ULK1 signaling pathway","volume":"20","author":"M Zhang","year":"2020","journal-title":"Oncology letters"},{"issue":"4","key":"pcbi.1010332.ref051","first-page":"1595","article-title":"Targeting tropomyosin-receptor kinase fused gene in cancer","volume":"34","author":"Y Chen","year":"2014","journal-title":"Anticancer research"},{"key":"pcbi.1010332.ref052","article-title":"Emerging roles of SRSF3 as a therapeutic target for cancer","volume":"1971","author":"Z Zhou","year":"2020","journal-title":"Frontiers in Oncology"},{"key":"pcbi.1010332.ref053","doi-asserted-by":"crossref","first-page":"304","DOI":"10.12659\/MSMBR.906289","article-title":"Targeting overexpressed activating transcription factor 1 (ATF1) inhibits proliferation and migration and enhances sensitivity to paclitaxel in esophageal cancer cells","volume":"23","author":"Q Hao","year":"2017","journal-title":"Medical Science Monitor Basic Research"},{"key":"pcbi.1010332.ref054","doi-asserted-by":"crossref","first-page":"e10820","DOI":"10.7717\/peerj.10820","article-title":"Abnormal expression of HOXD11 promotes the malignant behavior of glioma cells and leads to poor prognosis of glioma patients","volume":"9","author":"J Wang","year":"2021","journal-title":"PeerJ"},{"issue":"9","key":"pcbi.1010332.ref055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/gb-2003-4-9-r60","article-title":"DAVID: database for annotation, visualization, and integrated discovery","volume":"4","author":"G Dennis","year":"2003","journal-title":"Genome biology"},{"key":"pcbi.1010332.ref056","doi-asserted-by":"crossref","first-page":"770299","DOI":"10.3389\/fonc.2022.770299","article-title":"LMO1 Plays an Oncogenic Role in Human Glioma Associated With NF-\u03baB Pathway","volume":"12","author":"L Gao","year":"2022","journal-title":"Frontiers in oncology"},{"key":"pcbi.1010332.ref057","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.canlet.2019.07.001","article-title":"SDHC-related deficiency of SDH complex activity promotes growth and metastasis of hepatocellular carcinoma via ROS\/NF\u03baB signaling","volume":"461","author":"J Li","year":"2019","journal-title":"Cancer letters"},{"issue":"2","key":"pcbi.1010332.ref058","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1158\/2159-8290.CD-20-1513","article-title":"Sex-biased ZRSR2 mutations in myeloid malignancies impair plasmacytoid dendritic cell activation and apoptosis","volume":"12","author":"K Togami","year":"2022","journal-title":"Cancer discovery"},{"key":"pcbi.1010332.ref059","article-title":"Using unsupervised learning algorithms to identify essential genes associated with SARS-CoV-2 as potential therapeutic targets for COVID-19","author":"G Taheri","journal-title":"bioRxiv"},{"issue":"4","key":"pcbi.1010332.ref060","doi-asserted-by":"crossref","first-page":"253","DOI":"10.4161\/cbt.12.4.15954","article-title":"FoxO family members in cancer","volume":"12","author":"Y Zhang","year":"2011","journal-title":"Cancer biology & therapy"},{"key":"pcbi.1010332.ref061","doi-asserted-by":"crossref","first-page":"109510","DOI":"10.1016\/j.asoc.2022.109510","article-title":"Comprehensive analysis of pathways in Coronavirus 2019 (COVID-19) using an unsupervised machine learning method","volume":"128","author":"G Taheri","year":"2022","journal-title":"Applied Soft Computing"},{"issue":"4","key":"pcbi.1010332.ref062","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.bbadis.2009.12.009","article-title":"Pathological roles of MAPK signaling pathways in human diseases","volume":"1802","author":"EK Kim","year":"2010","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease"},{"issue":"49","key":"pcbi.1010332.ref063","doi-asserted-by":"crossref","first-page":"31189","DOI":"10.1073\/pnas.2017152117","article-title":"Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis","volume":"117","author":"J Yi","year":"2020","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"1","key":"pcbi.1010332.ref064","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semcancer.2018.03.001","article-title":"RAS-mediated oncogenic signaling pathways in human malignancies","volume":"54","author":"AQ Khan","year":"2019","journal-title":"Seminars in Cancer Biology"},{"issue":"3","key":"pcbi.1010332.ref065","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41568-020-00322-0","article-title":"Antitumour immunity regulated by aberrant ERBB family signalling","volume":"21","author":"S Kumagai","year":"2021","journal-title":"Nature Reviews Cancer"},{"issue":"1","key":"pcbi.1010332.ref066","first-page":"1","article-title":"mTOR signaling pathway and mTOR inhibitors in cancer: Progress and challenges","volume":"10","author":"Z Zou","year":"2020","journal-title":"Cell & Bioscience"},{"key":"pcbi.1010332.ref067","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.canlet.2019.05.024","article-title":"COMPASS Ascending: Emerging clues regarding the roles of MLL3\/KMT2C and MLL2\/KMT2D proteins in cancer","volume":"458","author":"RJ Fagan","year":"2019","journal-title":"Cancer letters"},{"issue":"3","key":"pcbi.1010332.ref068","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1158\/0008-5472.CAN-18-3374","article-title":"Genome-Wide CRISPR-Cas9 Screen Reveals Selective Vulnerability of ATRX-Mutant Cancers to WEE1 InhibitionWEE1 Inhibitors Selectively Kill ATRX-Deficient Cancer Cells","volume":"80","author":"J Liang","year":"2020","journal-title":"Cancer research"},{"issue":"12","key":"pcbi.1010332.ref069","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1080\/15384047.2018.1491506","article-title":"A novel co-existing ZCCHC8-ROS1 and de-novo MET amplification dual driver in advanced lung adenocarcinoma with a good response to crizotinib","volume":"19","author":"YC Zhu","year":"2018","journal-title":"Cancer Biology & Therapy"}],"updated-by":[{"DOI":"10.1371\/journal.pcbi.1010332","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T00:00:00Z","timestamp":1666828800000}}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1010332","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T14:07:05Z","timestamp":1666879625000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1010332"}},"subtitle":[],"editor":[{"given":"Anna R","family":"Panchenko","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2022,10,17]]},"references-count":69,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,10,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1010332","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.06.29.498062","asserted-by":"object"}]},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,17]]}}}